Drug Injury Watch

Side Effects News & Reports

From 2005 to the Present

All Articles by Tom Lamb

Tag: Merck

Plaintiffs Win the Latest Round in Long-Running Fosamax Femur Fracture Litigation

September 30, 2024

Federal Appeals Court Rejects Merck's Legal Defense of Federal Preemption in September 2024 (Posted by Tom Lamb at Drug Injury Watch) UPDATE: On June 16, 2025, the U.S. Supreme Court rejected Merck's petition for certiorari filed…
Continue reading…
Merck Wants The US Supreme Court To Reverse A Federal Appeals Ruling In Fosamax – Femur Fractures Litigation

September 18, 2017

At Issue Is Whether Failure-To-Warn Claims By Plaintiffs Are Blocked By Federal Preemption Legal Doctrine, As Merck Contends (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: U.S. Supreme Court Hearing For Fosamax Appeal…
Continue reading…
Fosamax – Femur Fracture Lawsuits In Federal Court MDL: March 2017 Appellate Court Ruling Reinstates Lawsuits

March 24, 2017

Third Circuit Panel Reverses Earlier Dismissal Of Plaintiffs Cases By District Court Judge Pisano On Federal Preemption Grounds (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: Supreme Court Agrees To Review Fosamax…
Continue reading…
Fall 2016 Update On Fosamax Femur Fracture Lawsuits Is Not Much Different Than What Was Reported A Year Ago

September 20, 2016

Bottom Line Is That The Fate Of These Lawsuits Against Merck Is In The Hands Of The U.S. Court of Appeals For The Third Circuit (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE:…
Continue reading…
Merck Provides First 2016 Update For Fosamax – Femur Fracture Products Liability Lawsuits

May 17, 2016

About 4,400 Cases Still Pending In Federal Court MDL As Well As New Jersey And California State Courts (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: On March 22, 2017 the Third Circuit…
Continue reading…
Fosamax – Femur Fracture Update September 2015: Litigation Remains In “Holding Pattern” Awaiting Appellate Court Rulings

September 18, 2015

More Than 4000 Cases Are Pending In Federal Court MDL And The New Jersey Consolidation But There Are No Trials Scheduled (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: On March 22, 2017…
Continue reading…
First 2015 Update On Fosamax Femur Fracture Litigation: Not Much New Information To Report Out

March 2, 2015

With New Jersey State Court Fosamax Lawsuits Now Assigned To Judge Mayer, We Hope These Cases Get Back On Track (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: On March 22, 2017 the Third Circuit Court…
Continue reading…
Fluoroquinolone Antibiotics Cipro, Avelox, And Levaquin Linked To Peripheral Neuropathy In First Large Epidemiologic Study

August 22, 2014

Neurology Medical Journal Article Reports Two-Times Increased Risk For This Nerve Damage Side Effect For New Users Of These Antibiotics (Posted by Tom Lamb at DrugInjuryWatch.com) The popular antibiotics Levaquin (levofloxacin), Cipro (ciprofloxacin), Avelox (moxifloxacin) are…
Continue reading…
June 2014 Fosamax – Femur Fracture Litigation Update: Thousands Of Cases Pending, But No Trial Dates Currently Scheduled In Federal Court MDL Nor New Jersey Multicounty Litigation

June 6, 2014

Merck Corporate SEC Filing for First Quarter 2014 Provides Information About Numbers Of Lawsuits In Various Court Jurisdictions Being Worked Up For Some Possible Trials In The Future (Posted by Tom Lamb at DrugInjuryWatch.com)…
Continue reading…
Testosterone Drugs Litigation April 2014 Update: Legal & Medical Developments: AndroGel Federal Court MDL Motion Is Filed, And A “Low-T” Medical Study Is Criticized

April 1, 2014

Increasing Number Of AndroGel / Axiron / Testim Lawsuits Allege Heart Attacks And Strokes, With Highest Side Effects Risks Being For Older Men Or Those With Cardiac Conditions (Posted by Tom Lamb at DrugInjuryWatch.com)…
Continue reading…